Hang Lung Properties (00101) Reports Annual Results: Underlying Profit Attributable to Shareholders Rises 3% to HK$3.202 Billion, Final Dividend of HK$0.40

Stock News
01/30

Hang Lung Properties (00101) announced its full-year results for the 2025 fiscal year, revealing total revenue of HK$9.950 billion, which represents an 11% decrease compared to the previous year, primarily due to an 83% decline in property sales revenue to HK$264 million. Overall operating profit increased by 1% to HK$6.527 billion. Impacted by the persistent weakness in the mainland office leasing market and a slower-than-expected economic recovery in Hong Kong, property rental income and operating profit both decreased by 1%, to HK$9.389 billion and HK$6.663 billion, respectively. The expansion of the hotel property portfolio drove a 57% increase in related revenue to HK$297 million, while the operating loss, after accounting for asset depreciation, narrowed by 46% to HK$34 million. Underlying profit attributable to shareholders rose by 3% to HK$3.202 billion. The narrowing of the loss from property sales was sufficient to offset the impact of the decline in operating profit from property leasing and the increase in finance costs resulting from a reduction in capitalized interest. Basic earnings per share were HK$0.65. A final dividend of HK$0.40 per share is proposed. After including a net revaluation loss on investment properties attributable to shareholders of HK$1.396 billion (2024: HK$942 million), Hang Lung Properties recorded a profit attributable to shareholders of HK$1.806 billion (2024: HK$2.153 billion), with corresponding earnings per share of HK$0.37 (2024: HK$0.46). The company continues to be committed to developing projects conducive to its long-term development goals, expanding its business footprint in key cities, enhancing customer experience, and strictly selecting capital-efficient projects for reinvestment through its "Hang Lung V.3" strategy, thereby strengthening its business scale, visibility, and accessibility. Over the past year, the company announced a series of "Hang Lung V.3" strategic projects, including the Shangyi Street project at Kunming Spring City 66, the Hangzhou West Lake 66 expansion project, the Wuxi Center 66 expansion project, and the commercial operation project at 1038 West Nanjing Road in Shanghai. Benefiting from the "Hang Lung V.2" strategy's focus on developing core business districts in mainland China, the "Hang Lung V.3" strategy concentrates on maximizing the benefits of existing assets, reducing capital requirements, and aligning with government policies. Other projects under development include the Phase Two development of Wuxi Center 66, Hangzhou West Lake 66, the expansion of Shanghai Center 66, and the remaining integrated development project at Shenyang Palace 66.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10